Tormod Fladby

16.9k total citations · 1 hit paper
129 papers, 4.8k citations indexed

About

Tormod Fladby is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Tormod Fladby has authored 129 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Psychiatry and Mental health, 60 papers in Physiology and 28 papers in Cognitive Neuroscience. Recurrent topics in Tormod Fladby's work include Dementia and Cognitive Impairment Research (69 papers), Alzheimer's disease research and treatments (57 papers) and Advanced Neuroimaging Techniques and Applications (22 papers). Tormod Fladby is often cited by papers focused on Dementia and Cognitive Impairment Research (69 papers), Alzheimer's disease research and treatments (57 papers) and Advanced Neuroimaging Techniques and Applications (22 papers). Tormod Fladby collaborates with scholars based in Norway, Sweden and United Kingdom. Tormod Fladby's co-authors include Dag Aarsland, Per Selnes, J.B.M.J. Jansen, Erik Hessen, Vidar Stenset, Atle Bjørnerud, Eirik Auning, Deborah L. Croteau, Nektarios Tavernarakis and Beimeng Yang and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Nature Neuroscience.

In The Last Decade

Tormod Fladby

124 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease

2019 1.3k citations Tormod Fladby et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tormod Fladby Norway	33	1.8k	1.4k	1.2k	872	782	129	4.8k
Eric E. Abrahamson United States	31	1.8k 1.0×	840 0.6×	869 0.7×	466 0.5×	721 0.9×	61	4.0k
Lidia Glodzik United States	32	2.3k 1.3×	1.1k 0.8×	923 0.8×	835 1.0×	687 0.9×	78	4.6k
Claire Paquet France	34	1.8k 1.0×	1.0k 0.7×	1.0k 0.9×	707 0.8×	686 0.9×	177	4.4k
Michael S. Rafii United States	33	1.7k 0.9×	1.3k 0.9×	979 0.8×	599 0.7×	286 0.4×	112	4.8k
Kevin Taddei Australia	40	3.0k 1.6×	1.6k 1.1×	1.3k 1.1×	796 0.9×	388 0.5×	123	5.7k
Claudio Mariani Italy	37	1.3k 0.7×	899 0.6×	741 0.6×	923 1.1×	1.2k 1.5×	125	4.3k
Maria Bjerke Belgium	32	2.2k 1.2×	1.8k 1.2×	1.2k 1.0×	872 1.0×	572 0.7×	79	4.2k
Shorena Janelidze Sweden	39	3.5k 1.9×	2.9k 2.0×	1.3k 1.1×	1.3k 1.5×	820 1.0×	114	6.6k
Mirosław Bryś United States	27	2.3k 1.2×	1.3k 0.9×	666 0.6×	711 0.8×	733 0.9×	47	3.9k
Madhav Thambisetty United States	43	3.4k 1.9×	1.3k 0.9×	2.8k 2.4×	917 1.1×	599 0.8×	115	6.7k

Countries citing papers authored by Tormod Fladby

Since Specialization

Citations

This map shows the geographic impact of Tormod Fladby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tormod Fladby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tormod Fladby more than expected).

Fields of papers citing papers by Tormod Fladby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tormod Fladby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tormod Fladby. The network helps show where Tormod Fladby may publish in the future.

Co-authorship network of co-authors of Tormod Fladby

This figure shows the co-authorship network connecting the top 25 collaborators of Tormod Fladby. A scholar is included among the top collaborators of Tormod Fladby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tormod Fladby. Tormod Fladby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

González‐Ortiz, Fernando, Bjørn‐Eivind Kirsebom, Lene Pålhaugen, et al.. (2025). Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease. Neurology. 104(11). e213676–e213676. 3 indexed citations

Tovar, Diego, Francisco Lopera, David Aguillón, et al.. (2025). Characterizing resting-state EEG oscillatory and aperiodic activity in neurodegenerative diseases: A multicentric study. Computers in Biology and Medicine. 197(Pt B). 111080–111080. 1 indexed citations

Aarsland, Dag, A. Sunde, Diego Tovar, et al.. (2025). Prevalence of Alzheimer’s disease pathology in the community. Nature. 650(8100). 182–186. 1 indexed citations

González‐Ortiz, Fernando, Thomas K. Karikari, Daniëlle te Vruchte, et al.. (2024). Plasma phosphorylated-tau217 is increased in Niemann–Pick disease type C. Brain Communications. 6(6). fcae375–fcae375. 7 indexed citations

González‐Ortiz, Fernando, Thomas K. Karikari, Bjørn‐Eivind Kirsebom, et al.. (2024). Neuronal plasma biomarkers in acute ischemic stroke. Journal of Cerebral Blood Flow & Metabolism. 45(1). 77–84. 6 indexed citations

Kirsebom, Bjørn‐Eivind, et al.. (2024). Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases. Journal of Alzheimer s Disease. 100(s1). S93–S101. 2 indexed citations

Wettergreen, Marianne, et al.. (2023). Alzheimer’s disease risk genes are differentially expressed upon Lipopolysaccharide stimulation in a myelogenic cell model. Alzheimer s & Dementia. 19(S12). 3 indexed citations

Aaseth, Jan, Trygve Holmøy, Kaj Blennow, et al.. (2023). CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred. Brain Sciences. 13(11). 1511–1511.

Öhman, Fredrik, Marie Eckerström, Erik Hessen, et al.. (2023). Demographically adjusted Rey–Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49–77 years and comparison with North American norms. Scandinavian Journal of Psychology. 65(2). 168–178. 2 indexed citations

10.

Borda, Miguel Germán, Daniel Ferreira, Per Selnes, et al.. (2022). Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness. Dementia and Geriatric Cognitive Disorders. 51(1). 63–72. 4 indexed citations

11.

Kirsebom, Bjørn‐Eivind, Tormod Fladby, Knut Waterloo, et al.. (2022). Regression-based cognitive change norms applied in biochemically defined predementia Alzheimer’s disease.. Neuropsychology. 37(1). 32–43. 5 indexed citations

12.

Hessen, Erik, Knut Waterloo, Geir Bråthen, et al.. (2021). Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample. Applied Neuropsychology Adult. 30(2). 159–168. 18 indexed citations

13.

Fladby, Tormod, Bjørn‐Eivind Kirsebom, Knut Waterloo, et al.. (2020). Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer’s pathology and progression to dementia.. Neuropsychology. 34(8). 851–861. 13 indexed citations

14.

Hessen, Erik, Knut Waterloo, Marie Eckerström, et al.. (2020). Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years. The Clinical Neuropsychologist. 34(sup1). 110–126. 30 indexed citations

15.

Ballard, Clive, Dag Aarsland, Jeffrey L. Cummings, et al.. (2020). Drug repositioning and repurposing for Alzheimer disease. Nature Reviews Neurology. 16(12). 661–673. 132 indexed citations

16.

Hope, Tuva R., Per Selnes, Irena Rektorová, et al.. (2019). Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson’s disease. PLoS ONE. 14(5). e0217922–e0217922. 14 indexed citations

17.

Hessen, Erik, Eirik Auning, Per Selnes, et al.. (2016). Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases. Journal of Parkinson s Disease. 6(2). 413–421. 11 indexed citations

18.

Wettergreen, Marianne, et al.. (2015). Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid. Biochimie. 113. 86–92. 9 indexed citations

19.

Coello, Christopher, Frode Willoch, Per Selnes, et al.. (2013). Correction of partial volume effect in 18F-FDG PET brain studies using coregistered MR volumes: Voxel based analysis of tracer uptake in the white matter. NeuroImage. 72. 183–192. 20 indexed citations

20.

Stenset, Vidar, Dag Hofoss, A. Berstad, et al.. (2008). White Matter Lesion Subtypes and Cognitive Deficits in Patients with Memory Impairment. Dementia and Geriatric Cognitive Disorders. 26(5). 424–431. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact